---
figid: PMC7174602__fimmu-11-00508-g0001
figlink: pmc/articles/PMC7174602/figure/F1/
number: F1
caption: 'Extracellular adenosine synthesis, adenosine receptor signaling, and adenosine-mediated
  immunosuppression. Extracellular adenosine and receptor signaling is part of a large
  cascade of ecto-enzymes (e.g., CD39, CD73), membrane transporters (e.g., ENTs),
  and G-protein-coupled (e.g., P2YR, adenosine receptors) and ionotrophic receptors
  (e.g., P2XR) known as the purinergic pathway. The purinergic pathway mediates both
  pro-inflammatory and anti-inflammatory responses. The breakdown of extracellular
  adenosine triphosphate (ATP) to extracellular adenosine is key to balancing tissue
  inflammation. Intracellular ATP is released by lytic (e.g., stressed and/or apoptotic/necrotic
  cells) and non-lytic (e.g., pannexin-1 and connexins) routes secondary to tissue
  damage, inflammation, and/or hypoxia. Once released, ATP activates ATP receptors
  (e.g., P2XR and P2YR) to promote pro-inflammatory responses, including the release
  of inflammatory cytokines promote lymphocyte proliferation, cell mobility, and phagocyte
  recruitment. ATP is dephosphorylated to extracellular adenosine by CD39, converting
  ATP and adenosine diphosphate (ADP) to adenosine monophosphate (AMP), and CD73,
  converting AMP to adenosine. Extracellular adenosine signaling through adenosine
  receptors (e.g., A1R, A2AR, A2BR, A3R) promotes anti-inflammatory responses, including
  the release of pro-tolerance cytokines, regulatory lymphocytes, and skewing toward
  M2 macrophages. Extracellular adenosine also can be taken up intracellularly by
  equilibrative nucleoside transporters (e.g., ENTs) or be further metabolized to
  inosine (e.g., ADA/CD26). A2AR and A2BR signaling stimulate adenylate cyclase to
  produce cyclic AMP (cAMP) which activates protein kinase A (PKA). A1R and A3R signaling
  inhibit adenylate cyclase. Adenosine receptors can activate multiple signaling pathways
  (e.g., MAPK, PI3K, PLC, PKC, ion channels), depending on cell and tissue types.
  Tumors exploit the anti-inflammatory actions of extracellular adenosine to evade
  antitumor immune cells. A3R activation on mast cells promotes tumor microenvironment
  (TME) remodeling and angiogenesis, increases the population of M2 macrophages, and
  promotes the accumulation of myeloid-derived suppressor cells (MDSCs) in tumors.
  A2AR activation on T regulatory cells (Tregs) enhances their immunosuppressive activity
  (e.g., suppressing effector T cells). A2AR and/or A2BR activation on natural killer
  (NK) cells, dendritic cells, and effector T cells dampens the antitumor activity
  of these cells. Abbreviations: ectonucleoside triphosphate diphosphohydrolase-1
  (CD39), ecto-5′nucleotidase (CD73), adenosine deaminase (ADA), phospholipase C (PLC),
  protein kinase C (PKC), diacylglycerol (DAG), phosphatidylinositol 4,5-bisphosphate
  (PIP2), inositol trisphosphate (IP3), mitogen-activated protein kinase (MAPK), phosphoinositide
  3-kinase (PI3K).'
pmcid: PMC7174602
papertitle: CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers.
reftext: Jerry B. Harvey, et al. Front Immunol. 2020;11:508.
pmc_ranked_result_index: '43284'
pathway_score: 0.9432695
filename: fimmu-11-00508-g0001.jpg
figtitle: Extracellular adenosine synthesis, adenosine receptor signaling, and adenosine-mediated
  immunosuppression
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7174602__fimmu-11-00508-g0001.html
  '@type': Dataset
  description: 'Extracellular adenosine synthesis, adenosine receptor signaling, and
    adenosine-mediated immunosuppression. Extracellular adenosine and receptor signaling
    is part of a large cascade of ecto-enzymes (e.g., CD39, CD73), membrane transporters
    (e.g., ENTs), and G-protein-coupled (e.g., P2YR, adenosine receptors) and ionotrophic
    receptors (e.g., P2XR) known as the purinergic pathway. The purinergic pathway
    mediates both pro-inflammatory and anti-inflammatory responses. The breakdown
    of extracellular adenosine triphosphate (ATP) to extracellular adenosine is key
    to balancing tissue inflammation. Intracellular ATP is released by lytic (e.g.,
    stressed and/or apoptotic/necrotic cells) and non-lytic (e.g., pannexin-1 and
    connexins) routes secondary to tissue damage, inflammation, and/or hypoxia. Once
    released, ATP activates ATP receptors (e.g., P2XR and P2YR) to promote pro-inflammatory
    responses, including the release of inflammatory cytokines promote lymphocyte
    proliferation, cell mobility, and phagocyte recruitment. ATP is dephosphorylated
    to extracellular adenosine by CD39, converting ATP and adenosine diphosphate (ADP)
    to adenosine monophosphate (AMP), and CD73, converting AMP to adenosine. Extracellular
    adenosine signaling through adenosine receptors (e.g., A1R, A2AR, A2BR, A3R) promotes
    anti-inflammatory responses, including the release of pro-tolerance cytokines,
    regulatory lymphocytes, and skewing toward M2 macrophages. Extracellular adenosine
    also can be taken up intracellularly by equilibrative nucleoside transporters
    (e.g., ENTs) or be further metabolized to inosine (e.g., ADA/CD26). A2AR and A2BR
    signaling stimulate adenylate cyclase to produce cyclic AMP (cAMP) which activates
    protein kinase A (PKA). A1R and A3R signaling inhibit adenylate cyclase. Adenosine
    receptors can activate multiple signaling pathways (e.g., MAPK, PI3K, PLC, PKC,
    ion channels), depending on cell and tissue types. Tumors exploit the anti-inflammatory
    actions of extracellular adenosine to evade antitumor immune cells. A3R activation
    on mast cells promotes tumor microenvironment (TME) remodeling and angiogenesis,
    increases the population of M2 macrophages, and promotes the accumulation of myeloid-derived
    suppressor cells (MDSCs) in tumors. A2AR activation on T regulatory cells (Tregs)
    enhances their immunosuppressive activity (e.g., suppressing effector T cells).
    A2AR and/or A2BR activation on natural killer (NK) cells, dendritic cells, and
    effector T cells dampens the antitumor activity of these cells. Abbreviations:
    ectonucleoside triphosphate diphosphohydrolase-1 (CD39), ecto-5′nucleotidase (CD73),
    adenosine deaminase (ADA), phospholipase C (PLC), protein kinase C (PKC), diacylglycerol
    (DAG), phosphatidylinositol 4,5-bisphosphate (PIP2), inositol trisphosphate (IP3),
    mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NT5E
  - ENTPD1
  - ADA
  - DPP4
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - PLCB3
  - PLCB4
  - PLCG1
  - PLCB1
  - PLCE1
  - PLCD4
  - PLCD3
  - PLCB2
  - PLCD1
  - PLCG2
  - PLCZ1
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - Inosine
  - Adenosine
  - Adenylate
  - IP
genes:
- word: CD73
  symbol: CD73
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
- word: CD39
  symbol: CD39
  source: hgnc_prev_symbol
  hgnc_symbol: ENTPD1
  entrez: '953'
- word: ADA/
  symbol: ADA
  source: hgnc_symbol
  hgnc_symbol: ADA
  entrez: '100'
- word: CD26
  symbol: CD26
  source: hgnc_prev_symbol
  hgnc_symbol: DPP4
  entrez: '1803'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: +MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
chemicals:
- word: Inosine
  source: MESH
  identifier: D007288
- word: Adenosine
  source: MESH
  identifier: D000241
- word: Adenylate
  source: MESH
  identifier: C017987
- word: IP
  source: MESH
  identifier: C062616
diseases: []
figid_alias: PMC7174602__F1
redirect_from: /figures/PMC7174602__F1
figtype: Figure
---
